Virus therapy joins chemo to fight rectal cancer
Disease control
Recruiting now
This trial tests a new treatment called NG-350A, a virus that targets tumor cells and boosts the immune system, combined with standard chemoradiotherapy. It is for adults with locally advanced rectal cancer who have a high risk of the cancer coming back. The goal is to see if thi…
Phase: PHASE1 • Sponsor: Akamis Bio • Aim: Disease control
Last updated Apr 24, 2026 16:17 UTC